Skip to Main Content

An official website of the United States government

Explore the HIP Breast Cancer Screening Trial
Access to Data

Main Findings

Major analyses of the primary trial endpoints were conducted at the 5, 7, and 18 year intervals from randomization and found that screening reduced mortality that was largely seen in the participants over the age of 50.